p53 mutation as a source of aberrant β-catenin accumulation in cancer cells
Authors:
Open Access
- 13 November 2002
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 21 (52) , 7971-7980
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 49 references indexed in Scilit:
- The IARC TP53 database: New online mutation analysis and recommendations to usersHuman Mutation, 2002
- Increased expression of β‐catenin predicts better prognosis in nonsmall cell lung carcinomasCancer, 2002
- NAPO as a novel marker for apoptosisJournal of Cell Biology, 2001
- Acquired expression of transcriptionally active p73 in hepatocellular carcinoma cellsOncogene, 2001
- A monoclonal antibody against DNA binding helix of p53 proteinOncogene, 2001
- Hepatocellular carcinoma in WHV/N-myc2 transgenic mice: oncogenic mutations of β-catenin and synergistic effect of p53 null allelesOncogene, 2000
- Involvement of adenomatous polyposis coli (APC)/β-catenin signalling in human breast cancerEuropean Journal of Cancer, 2000
- β‐Catenin Accumulation and Mutation of Exon 3 of the β‐Catenin Gene in Hepatocellular CarcinomaJapanese Journal of Cancer Research, 1999
- Genetic Aspects of Hepatocellular CarcinogenesisSeminars in Liver Disease, 1999
- From The Lancet: Ice-cream poisoningThe Lancet, 1991